Interstitial cystitis/painful bladder syndrome: epidemiology, pathophysiology and evidence-based treatment options.

[1]  N. Davis,et al.  Using Google Trends to assess global interest in 'Dysport®' for the treatment of overactive bladder. , 2013, Urology.

[2]  D. Engeler,et al.  The 2013 EAU guidelines on chronic pelvic pain: is management of chronic pelvic pain a habit, a philosophy, or a science? 10 years of development. , 2013, European urology.

[3]  N. Davis,et al.  Detecting internet activity for erectile dysfunction using search engine query data in the Republic of Ireland , 2012, BJU international.

[4]  L. Cardozo,et al.  Interstitial cystitis: diagnosis and management. , 2012, European journal of obstetrics, gynecology, and reproductive biology.

[5]  M. Hassouna,et al.  Efficacy of sacral neuromodulation in treatment of bladder pain syndrome: Long‐term follow‐up , 2011, Neurourology and urodynamics.

[6]  Ursula Wesselmann,et al.  AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. , 2011, The Journal of urology.

[7]  T. McGloughlin,et al.  Xenogenic extracellular matrices as potential biomaterials for interposition grafting in urological surgery. , 2010, The Journal of urology.

[8]  P. Hanno,et al.  A multicenter, randomized, double-blind, parallel group pilot evaluation of the efficacy and safety of intravesical sodium chondroitin sulfate versus vehicle control in patients with interstitial cystitis/painful bladder syndrome. , 2010, Urology.

[9]  P. Dinis,et al.  Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome/interstitial cystitis. , 2010, European Urology.

[10]  D. Engeler,et al.  EAU guidelines on chronic pelvic pain. , 2004, European urology.

[11]  M. Fall,et al.  Treatment of bladder pain syndrome/interstitial cystitis 2008: can we make evidence-based decisions? , 2008, European urology.

[12]  L. Rodríguez,et al.  Short-term results of bilateral S2-S4 sacral neuromodulation for the treatment of refractory interstitial cystitis, painful bladder syndrome, and chronic pelvic pain. , 2008, International urogynecology journal and pelvic floor dysfunction.

[13]  M. Fall,et al.  Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. , 2008, European urology.

[14]  C. Riedl,et al.  Hyaluronan treatment of interstitial cystitis/painful bladder syndrome , 2008, International Urogynecology Journal.

[15]  I. Ahmad,et al.  Sequential hydrodistension and intravesical instillation of hyaluronic acid under general anaesthesia for treatment of refractory interstitial cystitis: a pilot study , 2008, International Urogynecology Journal.

[16]  L. Rodríguez,et al.  Short-term results of bilateral S2–S4 sacral neuromodulation for the treatment of refractory interstitial cystitis, painful baldder syndrome, and chronic pelvic pain , 2008, International Urogynecology Journal.

[17]  C. Parsons,et al.  The role of the urinary epithelium in the pathogenesis of interstitial cystitis/prostatitis/urethritis. , 2007, Urology.

[18]  J. Mckinlay,et al.  Prevalence of painful bladder symptoms and effect on quality of life in black, Hispanic and white men and women. , 2007, The Journal of urology.

[19]  C. Fowler,et al.  Effect of intravesical Resiniferatoxin (RTX) on lower urinary tract symptoms, urodynamic parameters, and quality of life of patients with urodynamic increased bladder sensation. , 2006, European urology.

[20]  L. Hertle,et al.  Safety and efficacy of hyperbaric oxygen therapy for the treatment of interstitial cystitis: a randomized, sham controlled, double-blind trial. , 2006, The Journal of urology.

[21]  T. Tammela,et al.  Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative study. , 2005, The Journal of urology.

[22]  A. Gousse,et al.  Urinary uronate and sulfated glycosaminoglycan levels: markers for interstitial cystitis severity. , 2005, The Journal of urology.

[23]  K. O’Reilly,et al.  Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double-blind, placebo controlled trial. , 2005, The Journal of urology.

[24]  J. Blaivas,et al.  Long-term followup of augmentation enterocystoplasty and continent diversion in patients with benign disease. , 2005, The Journal of urology.

[25]  J. Nickel,et al.  Randomized, double-blind, dose-ranging study of pentosan polysulfate sodium for interstitial cystitis. , 2005, Urology.

[26]  J. Clemens,et al.  Prevalence and incidence of interstitial cystitis in a managed care population. , 2005, The Journal of urology.

[27]  R. Hautmann,et al.  Cystectomy and orthotopic ileal neobladder: the impact on female sexuality. , 2004, The Journal of urology.

[28]  L. Hertle,et al.  A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis. , 2004, The Journal of urology.

[29]  Jianfeng Xu,et al.  Prevalence of interstitial cystitis in first-degree relatives of patients with interstitial cystitis. , 2004, Urology.

[30]  E. Messing,et al.  A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis. , 2003, The Journal of urology.

[31]  Jialu Zhang,et al.  Changes in human bladder epithelial cell gene expression associated with interstitial cystitis or antiproliferative factor treatment. , 2003, Physiological genomics.

[32]  G. Steinhoff,et al.  The efficacy of chondroitin sulfate 0.2% in treating interstitial cystitis. , 2002, The Canadian journal of urology.

[33]  L. Hertle,et al.  Long-term results of trigone-preserving orthotopic substitution enterocystoplasty for interstitial cystitis. , 2002, The Journal of urology.

[34]  A. Haq,et al.  Oral cimetidine gives effective symptom relief in painful bladder disease: a prospective, randomized, double‐blind placebo‐controlled trial , 2001, BJU international.

[35]  D. Lubeck,et al.  Psychometric validation of the O'leary-Sant interstitial cystitis symptom index in a clinical trial of pentosan polysulfate sodium. , 2001, Urology.

[36]  John M. Park,et al.  Is interstitial cystitis an underdiagnosed problem in children? A diagnostic and therapeutic dilemma. , 2001, Urology.

[37]  R. Witherow,et al.  Oral cimetidine gives effective symptom relief in painful bladder disease: a prospective, randomized, double‐blind placebo‐controlled trial , 2001, BJU international.

[38]  M. Fall,et al.  Intravesical bacillus Calmette-Guerin and dimethyl sulfoxide for treatment of classic and nonulcer interstitial cystitis: a prospective, randomized double-blind study. , 2000, The Journal of urology.

[39]  M. Fall,et al.  Complete Transurethral Resection of Ulcers in Classic Interstitial Cystitis , 2000, International Urogynecology Journal.

[40]  R. Weiss,et al.  Urinary nitric oxide synthase activity and cyclic GMP levels are decreased with interstitial cystitis and increased with urinary tract infections. , 1996, The Journal of urology.

[41]  J. Nickel,et al.  Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. , 1996, The Journal of urology.

[42]  G. Sant,et al.  Standard intravesical therapies for interstitial cystitis. , 1994, The Urologic clinics of North America.

[43]  G. Sant,et al.  Pentosan polysulfate sodium for therapy of interstitial cystitis. A double-blind placebo-controlled clinical study. , 1990, Urology.

[44]  R. Perez-Marrero,et al.  A controlled study of dimethyl sulfoxide in interstitial cystitis. , 1988, The Journal of urology.

[45]  R. Barnes,et al.  Transurethral resection of Hunner's ulcer. , 1974, The Journal of urology.

[46]  M. Silk.  Bladder antibodies in interstitial cystitis. , 1970, The Journal of urology.